LABETALOL Nardia 5 mg/ml (100 mg per 20 ml) sol pe

7680703830017 CH-70383 C07AG01 02.03.0.

Active substances:

Labetaloli hydrochloridum

No images available

Details

Product number
7038301
CPT
-
Packaging group
5
Unit
Ampulle(n)
Composition
labetaloli hydrochloridum 100 mg, glucosum monohydricum 990 mg, dinatrii edetas, acidum hydrochloridum, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 20 ml corresp. natrium 0.274 mg.

Articles (1)

Labetalol Nardia 5 mg/ml (100 mg per 20 ml), Injektions-/Infusionslösung
Ampullen
5
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
02/07/2026
Professional SmPC
Français
02/07/2026
Professional SmPC
Italien
02/07/2026

Detailed composition

Substance Quantity Type Category
labetaloli hydrochloridum
100.0 MG Substance Wirkstoff (Principe actif)
glucosum monohydricum
990.0 MG Substance HBESI
dinatrii edetas
- Substance HNIDK
acidum hydrochloridum
- Substance HNIDK
natrii hydroxidum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
natrium
0.274 MG Substance HBESI

Authorization holder

Nardia Pharmaceuticals SA

6855 Stabio

Authorization information

Swissmedic authorization number
70383
Drug name
Labetalol Nardia, Injektions-/Infusionslösung
Galenic form
LSIN
ATC Code
C07AG01
Authorization status
Z
Dispensation category
B
First authorization
12/05/2026
Authorization expiration date
11/05/2031
IT number
02.03.0.
Domain
Human medicine
Field of application
Indiziert bei Patienten mit schwerer Hypertonie, wenn eine rasche Senkung des Blutdruckes erforderlich ist, unmittelbar nach der akuten Phase eines Myokardinfarktes sowie zur kontrollierten Blutdrucksenkung bei chirurgischen Eingriffen.

Packaging details

Description (FR)
LABETALOL Nardia 5 mg/ml (100 mg per 20 ml) sol pe
Description (DE)
LABETALOL Nardia 5 mg/ml (100 mg per 20 ml) Inf Lö
Market launch
01/09/2026
Narcotic (BTM)
No
Buy us a coffee Explore the data